Condition
MSS clinical trials and research
As of November 12, 2026, Find a Trial lists 5 MSS clinical trials that are recruiting, at sites in 2 countries (most in China (4), United States (1)). By phase: Phase 2 (3), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest MSS clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Short-course radiotherapy plus intensified chemotherapy and targeted therapy with immunotherapy for high-risk rectal cancer | Phase 3 | Guangzhou, Guangdong | Recruiting | Apr 24, 2026 |
| Direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal and gastrointestinal tumors | Phase 1 | Pittsburgh, Pennsylvania | Recruiting | Jun 3, 2025 |
| Short-course radiation plus CAPEOX chemotherapy and serplulimab for MSS/pMMR rectal cancer with limited metastases | Phase 2 | Hangzhou, Zhejiang | Recruiting | Feb 27, 2025 |
| Combination treatment for metastatic colorectal cancer | Phase 2 | Beijing, Beijing Municipality | Recruiting | Mar 20, 2024 |
| Neoadjuvant treatment for locally advanced rectal cancer using Serplulimab, CAPEOX, and Celecoxib | Phase 2 | Hangzhou, Zhejiang | Recruiting | Feb 16, 2023 |
All recruiting trials (5)
-
Short-course radiotherapy plus intensified chemotherapy and targeted therapy with immunotherapy for high-risk rectal cancer
This trial tests whether adding targeted therapy and a PD-1 inhibitor to a short course of radiotherapy and standard chemotherapy helps high-risk pMMR/MSS rectal cancer patients, compared with the same radiotherapy and chemotherapy alone.
-
Direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal and gastrointestinal tumors
This trial will try a single direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal tumors to see if it is safe for adults with advanced metastatic gastrointestinal or peritoneal cancers who have not responded to standard treatments.
-
Short-course radiation plus CAPEOX chemotherapy and serplulimab for MSS/pMMR rectal cancer with limited metastases
This trial will try combining short-course radiotherapy, CAPEOX chemotherapy, and the immunotherapy serplulimab to see if it helps people with MSS/pMMR rectal cancer who have a small number of metastases.
-
Combination treatment for metastatic colorectal cancer
This study is testing a combination of three drugs to see if it can help patients with certain types of metastatic colorectal cancer who have previously responded well to similar treatments.
-
Neoadjuvant treatment for locally advanced rectal cancer using Serplulimab, CAPEOX, and Celecoxib
This study is testing a new treatment combining an immune therapy and chemotherapy to see if it can help people with locally advanced rectal cancer before surgery.
Related topics
Quick answers
How many MSS clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.